F
Filip K. Knop
Researcher at University of Copenhagen
Publications - 523
Citations - 17834
Filip K. Knop is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 61, co-authored 437 publications receiving 13614 citations. Previous affiliations of Filip K. Knop include Copenhagen University Hospital & Victor Chang Cardiac Research Institute.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
Vanita R. Aroda,Jens Aberle,Lars Bardtrum,Erik Christiansen,Filip K. Knop,Sanaz Gabery,Sue D. Pedersen,John B. Buse +7 more
Journal ArticleDOI
SU18. GLP-1 Receptor Agonist Treatment in Schizophrenia Patients With Obesity
Journal ArticleDOI
10-LB: Dasiglucagon Ameliorates Postprandial Hypoglycemia after Roux-en-y Gastric Bypass
Casper K. Nielsen,Caroline Oehrstroem,Urd Kielgast,D.L. Hansen,Asger Lund,Tina Vilsbøll,Filip K. Knop +6 more
TL;DR: Administration of dasiglucagon effectively ameliorates postprandial hypoglycemia representing a promising new therapeutic option for management of postprandedial hypglycemia after RYGB.
Journal ArticleDOI
Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites
Annieke C.G. van Baar,Andrei Prodan,Camilla D. Wahlgren,Steen Seier Poulsen,Filip K. Knop,Albert K. Groen,Jacques J. Bergman,Max Nieuwdorp,Max Nieuwdorp,Max Nieuwdorp,Evgeni Levin +10 more
TL;DR: It is concluded that duodenal L cells associate with plasma metabolites that have been implicated in human glucose metabolism homeostasis that help to improve the (small intestinal-driven) pathophysiology behind insulin resistance in human obesity.
Journal ArticleDOI
Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes.
Niels Dalsgaard,Lærke S. Gasbjerg,Mads M. Helsted,L S Hansen,Nina L. Hansen,Kirsa Skov-Jeppesen,Bolette Hartmann,Jens J. Holst,Tina Vilsbøll,Filip K. Knop +9 more
TL;DR: In this article , the effect of alpha-glucosidase inhibitor acarbose on post-prandial bone resorption was investigated in patients with type 2 diabetes and used the GLP-1 receptor antagonist exendin(9-39)NH2.